Page last updated: 2024-09-05

methyl 4-azidophenylacetimidate and Parkinson Disease

methyl 4-azidophenylacetimidate has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Basu, BR; Choudhury, S; Das, N; Dey, S; Kumar, H; Pal, R1

Reviews

1 review(s) available for methyl 4-azidophenylacetimidate and Parkinson Disease

ArticleYear
Vitamin D deficiency and genetic polymorphisms of vitamin D-associated genes in Parkinson's disease.
    The European journal of neuroscience, 2023, Volume: 58, Issue:5

    Topics: Case-Control Studies; Genetic Predisposition to Disease; Genotype; Humans; Iran; Parkinson Disease; Polymorphism, Single Nucleotide; Receptors, Calcitriol; Vitamin D; Vitamin D Deficiency

2023